Persistent expression of autoantibodies in SLE patients in remission

Journal of Experimental Medicine

Volumn 203, Issue 10, 2006, Pages 2255-2261

  Yurasov, Sergey ^a,b   Tiller, Thomas ^c   Tsuiji, Makoto ^a   Velinzon, Klara ^a   Pascual, Virginia ^d   Wardemann, Hedda ^c   Nussenzweig, Michel C ^e  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL LYSATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AUTOANTIBODIES; B-LYMPHOCYTES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, IMMUNOGLOBULIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33749349457     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20061446     Document Type: Article

References (29)

1. Wardemann, H., S. Yurasov, A. Schaefer, J.W. Young, E. Meffre, and M.C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science. 301:1374-1377.
2. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M.C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201:703-711.
3. Tan, E.M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:93-151.
4. Davidson, A., and B. Diamond. 2001. Autoimmune diseases. N. Engl. J. Med. 345:340-350.
5. Stichweh, D., E. Arce, and V. Pascual. 2004. Update on pediatric systemic lupus erythematosus. Curr. Opin. Rheumatol. 16:577-587.
6. Arbuckle, M.R., M.T. McClain, M.V. Rubertone, R.H. Scofield, G.J. Dennis, J.A. James, and J.B. Harley. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349:1526-1533.
7. + memory B cell development. J. Exp. Med. 203:393-400.
8. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679-1689.
9. Dorner, T., and P.E. Lipsky. 2001. Immunoglobulin variable- region gene usage in systemic autoimmune diseases. Arthritis Rheum. 44:2715-2727.
10. Maciejewski, J.P., F.F. Weichold, and N.S. Young. 1994. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J. Immunol. 153:4303-4310.
11. Binder, D., J. Fehr, H. Hengartner, and R.M. Zinkernagel. 1997. Virus-induced transient bone marrow aplasia: major role of interferon-α/ β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185:517-530.
12. Bennett, L., A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711-723.
13. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009-1020.
14. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999-1008.
15. Prak, E.L., and M. Weigert. 1995. Light chain replacement: a new model for antibody gene rearrangement. J. Exp. Med. 182:541-548.
16. Bensimon, C., P. Chastagner, and M. Zouali. 1994. Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J. 13:2951-2962.
17. Samuels, J., Y.S. Ng, C. Coupillaud, D. Paget, and E. Meffre. 2005. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 201:1659-1667.
18. Melchers, F., and A.R. Rolink. 2006. B cell tolerance-how to make it and how to break it. Curr. Top. Microbiol. Immunol. 305:1-23.
19. Halverson, R., R.M. Torres, and R. Pelanda. 2004. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 5:645-650.
20. Retter, M.W., and D. Nemazee. 1998. Receptor editing occurs frequently during normal B cell development. J. Exp. Med. 188:1231-1238.
21. Casellas, R., T.A. Shih, M. Kleinewietfeld, J. Rakonjac, D. Nemazee, K. Rajewsky, and M.C. Nussenzweig. 2001. Contribution of receptor editing to the antibody repertoire. Science. 291:1541-1544.
22. Witsch, E.J., H. Cao, H. Fukuyama, and M. Weigert. 2006. Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J. Exp. Med. 203:1761-1772.
23. Wakeland, E.K., K. Liu, R.R. Graham, and T.W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 15:397-408.
24. Lesley, R., Y. Xu, S.L. Kalled, D.M. Hess, S.R. Schwab, H.B. Shu, and J.G. Cyster. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 20:441-453.
25. Mackay, F., S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J.L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1697-1710.
26. Gross, J.A., J. Johnston, S. Mudri, R. Enselman, S.R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:995-999.
27. Thien, M., T.G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 20:785-798.
28. Stohl, W., S. Metyas, S.M. Tan, G.S. Cheema, B. Oamar, D. Xu, V. Roschke, Y. Wu, K.P. Baker, and D.M. Hilbert. 2003. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 48:3475-3486.
29. Meffre, E., A. Schaefer, H. Wardemann, P. Wilson, E. Davis, and M.C. Nussenzweig. 2004. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J. Exp. Med. 199:145-150.